Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015

Details for Mechanism ID: 13696
Country/Region: Democratic Republic of the Congo
Year: 2013
Main Partner: Partnership for Supply Chain Management
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USAID
Total Funding: $5,245,438

SCMS is a multi-billion dollar PEPFAR Program managed by USAID and implemented by Partnership for Supply Chain Management (PfSCM). The purpose of SCMS is to ensure the supply of quality essential medicines and other products to people impacted by HIV/AIDS, and to promote sustainable supply chains in partner countries, in collaboration with US agencies and other stakeholders. SCMS supports the rapid scale up of HIV/AIDS prevention, care, and treatment through providing an uninterrupted supply of key commodities. As part of the USG strategy, the USG team is moving away from individual partner commodity procurement to this centralized mechanism. During FY 2012, only USAID will be putting money into this mechanism for its partners, but depending on the success of this procurement mechanism, CDC plans to program their commodities through this mechanism during COP 2013.

Funding for Care: Adult Care and Support (HBHC): $300,000

This is for the procurement of cotrimoxazole and limited therapeutic feeding supplements in USAID supported sites.

Funding for Care: TB/HIV (HVTB): $0

These funds will be used for the purcahse of TB-related test kits. Due to large pipeline issues, we gave USAID's main TB partner, TB2015, only minimal funding. These additional resources reflect the country's strategy of moving away from indvidual partner procurements for drugs to a centralized mechanism.

Funding for Care: Pediatric Care and Support (PDCS): $20,000

These funds will be used to purchase commodities for early infant diagnosis.

Funding for Laboratory Infrastructure (HLAB): $875,438

These funds will be used to purchase lab commodities for USAID supported sites.

Funding for Health Systems Strengthening (OHSS): $450,000

The USG considers the use of and strengthening of FEDECAME as critical to long term sustainability and has the potential to lead to better drug availability, cost effectiveness, reduction of drug stock-outs, and ultimately to the improved health of the population. Under GHI, the USG will collaborate with other development partners to complement and not duplicate efforts. SCMS will work in partnership and collaboration with SIAPS to improve the supply management system within the DRC and will support the USG efforts to pilot direct procurement through the FEDECAME.

Funding for Testing: HIV Testing and Counseling (HVCT): $200,000

These funds will be used for mobile and facilities based counseling and testing commodities sites supported by USAID.

Funding for Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT): $2,000,000

Most PMTCT commodities are budgeted with Acceleration Funding money ($3,410,000). This additional funding reflects the requirement that the DRC country team still needed to budget for PMTCT commodities in its normal budget.

Funding for Treatment: ARV Drugs (HTXD): $1,400,000

These funds will be used for the purchase of ARVs for patients identifed through PMTCT, PITC, or Key Populations activities.

Subpartners Total: $0
Management Sciences for Health: NA
Cross Cutting Budget Categories and Known Amounts Total: $56,000
Motor Vehicles: Purchased $56,000